Iran Med is a specialized exhibition in the field of medical equipment that operates in accordance with international standards. The main goal of this exhibition is to enhance the level of knowledge and technical information in the field of medical equipment. Iran Med aims to provide an active and dynamic platform for the exchange of ideas and new trends in this field through the organization of flexible and dynamic exhibitions.
Diabetes Care in the School
Ensuring that students with diabetes have the health services they need in school is important in helping them stay healthy and ready to learn. Managing diabetes at school is most effective when there is a partnership among students, parents, school nurses, health care providers, teachers, counselors, coaches, transportation staff, food service employees, and administrators. Support may include helping a student take medications, check blood sugar levels, choose healthy foods in the cafeteria, and be physically active.
Managing Diabetes at School
Diabetes doesn’t have to get in the way of a good experience at school. Remember, parents and schools have the same goal: to ensure that students with diabetes are safe and that they’re able to learn in a supportive environment. Schools can:
- Develop a plan to help students care for diabetes and handle any diabetes-related emergencies, including updated physician and emergency contacts.
- Work with a student’s parents, doctor, and school staff to create a Diabetes Medical Management Plan including information on services the school will provide and how to recognize high and low blood sugar levels.
- Ensure that school staff have a glucagon emergency kit and know how to use it if a student experiences a low blood sugar emergency.
Parents play an important role in making sure the school is informed and kept up to date on their child’s type 1 diabetes management. They will work with principals, designated school staff and health professionals to ensure that everyone involved knows what they have to do to keep their child healthy, safe and able to take part in all the opportunities of school life. It’s the parent’s responsibility to tell school their child has diabetes as soon as possible. Students’ parents should give teachers and coaches fact sheets about diabetes and extra snacks to keep on-hand. Prepare school staff for highs and lows. All adults who supervise children should know how to use your child’s diabetes to-go kit. They should be able to identify and treat hypoglycemia and hyperglycemia.
Diabetes Self-Management
Help students to manage diabetes at a level right for his or her age.
- If a child is going to monitor his or her blood sugar, ensure that he or she feels comfortable doing so.
- If a trained school employee will do the monitoring, be sure the student knows where and when to go for testing.
- Encourage students to eat healthy foods, including a healthy breakfast, which will help students stay focused and active.
- Having diabetes doesn’t mean that a child can’t be physically active or participate in physical education classes. They should get at least 60 minutes of physical activity every day. In fact, being active can help a child improve his or her blood sugar control.
Check that students with diabetes have all recommended vaccinations, including the flu shot. If a child with diabetes gets sick, he or she can take longer to recover than children without diabetes. Student’s parents Should be make sure that their child has all the vaccinations they need before starting the school year. Encourage students to wash their hands regularly, especially before eating and after using
Diabetes & Heat, How to Manage Diabetes in Summer?
Certain diabetes complications, such as damage to blood vessels and nerves, can affect your sweat glands so your body can’t cool as effectively. That can lead to heat exhaustion and heat stroke, which is a medical emergency.
People with diabetes get dehydrated (lose too much water from their bodies) more quickly. Not drinking enough liquids can raise blood sugar, and high blood sugar can make you urinate more, causing dehydration. Some commonly used medicines like diuretics (“water pills” to treat high blood pressure) can dehydrate you too.
High temperatures can change how your body uses insulin. You may need to test your blood sugar more often and adjust your insulin dose and what you eat and drink.
Warm-weather wisdom:
- Drink plenty of water—even if you’re not thirsty—so you don’t get dehydrated.
- Avoid alcohol and drinks with caffeine, like coffee, soda, and energy or sports drinks. They can lead to water loss and spike your blood sugar levels.
- Check your blood sugar before, during, and after you’re active. You may need to change how much insulin you use.
- Wear loose-fitting, lightweight, light-colored clothing.
- Wear sunscreen and a hat when you’re outside. Sunburn can raise your blood sugar levels.
- Don’t go barefoot, even on the beach or at the pool.
- Use your air conditioner or go to an air-conditioned building or mall to stay cool. In very high heat, a room fan won’t cool you enough.
- Get medical attention for heat-related illness.
- Have a go-bag ready for emergencies.
- Keep medicines, supplies, and equipment out of the heat.
Blood sugar measurement for the screening of diabetes among the employees of Hitco Group
In celebration of National Diabetes Week, blood sugar measurements were conducted for the employees at Hitco Group as a diabetes screening initiative. The aim of this activity was to raise awareness about the risk factors for diabetes, emphasize the importance of a healthy diet, and encourage regular medical check-ups. It is hoped that by carrying out such activities, we can take effective steps towards raising awareness and promoting the health of our esteemed colleagues at Hitco.
Participation of Hitco Holding in the Fourth International Congress on Diabetes Management
The Fourth International Congress on Diabetes Management took place on the 9th and 10th of November at the Institute of Nutritional Research and Food Industries of the country.
The congress, featuring prominent domestic and international speakers and more than 300 participants, including endocrinologists, internal medicine specialists, and distinguished diabetologists, was conducted in the form of workshops.
The main topics of the congress, focused on diabetic patients, included:
- Cardiovascular diseases
- Control of cardiovascular diseases
- Lifestyle modification and improvement
- Latest developments in diabetes control in type 1 and 2 patients
In this event, Rasta Imen Darou Company, with the Apotex brand as one of its main supporters, introduced its Apometformin product to healthcare professionals. Additionally, Dr. Saeed Kalbasi, an endocrinology specialist representing the Apotex brand, presented a workshop on the management of pre-diabetic patients.
Rasta Imen Darou Company, the official representative of Apotex Canada, as a continuous supplier of Apometformin through local production, is a supporter of diabetic patients. Moreover, by participating in educational workshops for physicians, it aims to enhance the general knowledge of the community in this field. For this purpose, it welcomes educational programs such as Gabric Vida.
The opening of the 20th conference of the Iranian Pharmacists Association with the presence of the head of the Food and Drug Organization
This conference was opened with the presence of Dr. Seyed Heydar Mohammadi, the head of the Food and Drug Organization. After the opening ceremony, in his first visit, he visited the booths of the Health Investment Tamin Group (Hitco).
In this visit, the products of Hitco Holding’s subsidiary companies were introduced to him by Dr. Kamali, CEO of Hitco Holding.
The products provided by Hitco Holding’s subsidiary companies included cosmetics, sports supplements, food supplements, and medical equipment.
Hitco Group partnership with Virtual Diabetes Academy of Gabric (VIDA)
Rasta Imen Darou (as one of the most prominent subsidiaries of the group) is proud to be in cooperation with Gabric diabetes association, around the education of the health care professionals, through an online platform, developed in collaboration with Iranian reputable academic physicians.
This digital platform (named as VIDA), has facilitates the remote training of the enthusiasts, while empowers the participants of the program, with the latest treatment methodologies, around this therapeutic area.
This action is in accordance with the commitment of Hitco Group, around education of the Iranian healthcare community, thus, enhanced patient care.
APOTEX of Canada, is officially represented in Iran by Rasta Imen Darou and has managed to localize the production of APO-Metformin, one of the well-known and respected brands of metformin.
Do Not Use Certain SD Biosensor Pilot COVID-19 At-Home Tests: FDA Safety Communication
The U.S. Food and Drug Administration (FDA) is warning consumers and health care providers to stop using and throw out certain lots of recalled SD Biosensor, Inc. Pilot COVID-19 At-Home Tests, distributed by Roche Diagnostics. The FDA has significant concerns of bacterial contamination in the Pilot COVID-19 At-Home Test liquid solution, provided in the test kit. Direct contact with the contaminated liquid solution may pose safety concerns and the bacterial contamination could impact the performance of the test.
SD Biosensor, Inc. has initiated a recall for all impacted SD Biosensor Pilot COVID-19 At-Home Tests that were distributed by Roche Diagnostics to certain retailers in the United States. Approximately 500,000 tests were distributed to CVS Health, as well as about 16,000 tests to Amazon. The FDA is working with Roche Diagnostics to understand how many of those tests were sold to consumers.
Importantly, none of the impacted lots were distributed through COVID.gov/tests – Free at-home COVID-19 tests or as part of other federal testing programs. If you received your tests through the COVID.gov/tests distribution or as part of other federal testing programs, they are not subject to this safety communication or product recall.
The FDA is advising consumers to stop using and throw out Pilot COVID-19 At-Home Test kits with the following lot numbers:
Recommendations for Consumers, Test Users, and Caregivers
- Check to see if your SD Biosensor Pilot COVID-19 At-Home Test is included in the SD Biosensors product recall by comparing the lot number.
- Do not use test kits with the affected lot numbers listed above. Throw out the entire test kit in the household trash. Do not pour the liquid solution down the drain. Additional information can be found in the Quick Reference Instructions for patients.
- If the liquid in the tube contacts your skin and eyes, flush with large amounts of water. If irritation persists, seek medical attention.
- Watch for signs of bacterial infection caused by exposure to the contaminated liquid solution. If you see signs of infection, such as fever, discharge, red eyes, or any other concerning symptoms, seek medical attention.
- Talk to your health care provider if you think you were tested with an affected Pilot COVID-19 At-Home Test, or if you have concerns about your test results.
Recommendations for Health Care Providers and Testing Program Organizers
- If an antigen test was performed less than two weeks ago using the Pilot COVID-19 At-Home Test, consider retesting your patients using an FDA authorized or cleared SARS-CoV-2 diagnostic test if you suspect an inaccurate result. If testing was performed more than two weeks ago and there is no reason to suspect current SARS-CoV-2 infection, it is not necessary to retest.
- If a patient presents with signs of bacterial infection, such as fever, conjunctivitis, or other signs or symptoms of systemic infection, consider whether they have recently used a Pilot COVID-19 At-Home Test. If they have, consider whether their infection may be from exposure to the contaminated buffer solution.
- Report any problems you experience with the Pilot COVID-19 At-Home Test to the FDA, including suspected false results. See Reporting Problems with Your Test.
Potential Risks
The liquid solution provided in the affected Pilot COVID-19 At-Home Test kits has been found to be contaminated with organisms such as Enterococcus, Enterobacter, Klebsiella and Serratia species. Individuals performing the self-test may run the risk of direct contact with the contaminated liquid in the tube. The liquid is contained in an individual, ready-to-use, pre-filled and sealed tube, but a user may inadvertently come in direct contact with contaminated liquid buffer during opening the tube or handling of the open tube or while performing the test.
Infection from bacteria such as Enterococcus, Enterobacter, Klebsiella and Serratia species may cause illness in people with weakened immune systems or those with direct exposure to the contaminated liquid solution through standard handling, accidental spills, or misuse of the product.
In addition to the risk of infection, this contamination may impact the performance of the test, and false results may occur.
- A false-negative antigen test result means that the test says the person does not have COVID-19 but they actually do have COVID-19. A false-negative result may lead to delayed diagnosis or inappropriate treatment of SARS-CoV-2, which may cause people harm including serious illness and death. False-negative results can also lead to further spread of the SARS-CoV-2 virus, including when people are housed together in health care, long-term care, and other facilities due to these false test results. When false negative test results are received, actions to limit exposure to an infected person might not be taken, such as isolating people, limiting contact with family and friends, or limiting access to places of employment.
- A false-positive antigen test result means that the test says the person has COVID-19 but they actually do not have COVID-19. A false-positive result may lead to a delay in both the correct diagnosis and appropriate treatment for the actual cause of a person’s illness, which could be another life-threatening disease that is not COVID-19. False-positive results could also lead to further spread of the SARS-CoV-2 virus when presumed positive people are housed together.
The FDA has not received reports of injuries, adverse health consequences, or death associated with use of the SD Biosensor Pilot COVID-19 At-Home Test to date.
source: https://www.fda.gov/medical-devices/safety-communications/do-not-use-certain-sd-biosensor-pilot-covid-19-home-tests-fda-safety-communication